Back
Trevi Therapeutics 10K Form
Buy
52
TRVI
Trevi Therapeutics
Last Price:
$4.27
Seasonality Move:
58.97%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TRVI News And Ratings
See the #1 stock for the next 7 days that we like better than TRVI
TRVI Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-9.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.78 |
| Price / Book: | 5.57 |
Profitability
| EPS (TTM): | -0.44000 |
|---|---|
| Net Income (TTM): | $-44.3M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Trevi Therapeutics Earnings Forecast
Key Trevi Therapeutics Financial Ratios
-
The Interest Expense is -1.35% of Operating Income.
-
Per Share Earnings over the last 7 years have been positive in 5 years.
Trevi Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | TRVI |
| CUSIP: | 89532M |
| Website: | trevitherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
TRVI Technical Analysis vs Fundamental Analysis
Buy
52
Trevi Therapeutics (TRVI)
is a Buy
Is Trevi Therapeutics a Buy or a Sell?
-
Trevi Therapeutics stock is rated a BuyThe current Trevi Therapeutics [TRVI] share price is $4.27. The Score for TRVI is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.